Oncology Central

Factors affecting the adoption and use of gene expression profiling by oncologists in clinical practice


Aim: In this study, we evaluated the association between oncologists’ perceptions of and attitudes toward one frequently used gene expression profiling assays, the Oncotype DX® and oncologists’ intention to use this assay in making treatment recommendations for breast cancer patients. Methods: A nationally representative sample of breast cancer oncologists was surveyed using an adapted technology acceptance model.

To view restricted content, please:


Leave A Comment